Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-993X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway ; volume:20 ; number:1 ; day:22 ; month:7 ; year:2019 ; pages:1-13 ; date:12.2019
Respiratory research ; 20, Heft 1 (22.7.2019), 1-13, 12.2019
- Urheber
-
Li, Lingxia
Zhao, Jing
Zhou, Li
Chen, Jie
Ma, Yuanyuan
Yu, Yanyan
Cheng, Jun
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12931-019-1102-2
- URN
-
urn:nbn:de:101:1-2019122221265464194574
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Lingxia
- Zhao, Jing
- Zhou, Li
- Chen, Jie
- Ma, Yuanyuan
- Yu, Yanyan
- Cheng, Jun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Hesperidin ameliorates bleomycin-induced experimental pulmonary fibrosis via inhibition of TGF-β1/Smad3/AMPK and IκBα/NF-κB pathways
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
Bleomycin-induced genome structural variations in normal, non-tumor cells
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
A critical role of AREG for bleomycin-induced skin fibrosis
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
Gut microbiota modulates bleomycin-induced acute lung injury response in mice
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Hesperidin ameliorates bleomycin-induced experimental pulmonary fibrosis via inhibition of TGF-β1/Smad3/AMPK and IκBα/NF-κB pathways
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
Bleomycin-induced genome structural variations in normal, non-tumor cells
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
A critical role of AREG for bleomycin-induced skin fibrosis
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice
Gut microbiota modulates bleomycin-induced acute lung injury response in mice
Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
Hesperidin ameliorates bleomycin-induced experimental pulmonary fibrosis via inhibition of TGF-β1/Smad3/AMPK and IκBα/NF-κB pathways
Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
Bleomycin-induced genome structural variations in normal, non-tumor cells
Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy
A critical role of AREG for bleomycin-induced skin fibrosis
Zafirlukast ameliorates lipopolysaccharide and bleomycin-induced lung inflammation in mice
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice